J-Pac Medical, the leading manufacturing and packaging outsourcing partner to medical companies, is sponsoring and attending the 2019 MPO Summit. This event, occurring October 3-4 at Marriott San Francisco Waterfront Hotel, will bring together experts from industry OEMs, contract manufacturers, suppliers, consultants, members of the investment community, and academia.
J-Pac Medical offers Diagnostic Reagent sample kits to give your company the ability to evaluate, test, and improve your product before you go into full production. You can choose water-filled kits (to test form and function while saving the cost of using your reagents), or you can supply the reagent fluid for realistic prototype testing. Order in quantities as low as 25.
Experiment with samples to compress your development time, reduce costs, and improve your POC diagnostic tests.
The requirements for validating the back-end processes for packaging, manufacturing, sterilization and shelf life of a sterile medical device are often misunderstood. Errors and oversights can result in failed validation tests and longer-term sterile barrier reliability.
Multiple factors are impacting the closing, but critical, processes associated with the end of product manufacturing.
Packaging and sterilization are critical stages of medical device manufacturing—lives are on the line if sterilization is compromised through packaging or sterilization failures. Both sterilization and packaging markets remain mature, relying on standard, accepted materials and methods. The most prevalent materials are legacy materials such as Tyvek and nylon. Large-scale sterilization depends on the well-established ethylene oxide (EO) and gamma radiation processes. FDA and ISO standards continue to become more stringent, especially regarding quality. OEMs focus on how to abide by these standards, which can seem open to interpretation. Everyone is pressured to reduce costs.
J-Pac Introduces 3D Printing of Functional Medical Device Prototypes
Using a unique technology, J-Pac produces functional components 1.4 times stronger than acrylonitrile butadiene styrene (ABS) as well as components that can replicate machined aluminum. The technology also allows J-Pac to supplement its in-house machine shop with quick-turn tooling capabilities.
“The manufacturing costs to produce end-use qualitymedical device plastic prototypes can be very high and involve long lead-times. Traditional 3D printing can be helpful to evaluate a part’s look and fit but lack the strength to properly evaluate functionality. J-Pac’s 3D printing services go beyond these limitations by producing extremely strong prototypes that can be used to evaluate the rigors that the final part would experience,” said Jeff Barrett, CEO of J-Pac Medical.